FDA Inspection
Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. – FDA Inspection, Mar 22, 2024
Record Details
This FDA Inspection record concerns Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., with an inspection on March 22, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 22, 2024
- Product Type
- Drugs
View Company Profile
ID · cf9a8a5c-015b-4e96-9e37-569ab49147b1
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1235782
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
- FDA Inspection 989604 - 2016-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.